Events Calendar

EPI Special Seminar: A path for novel therapeutic opportunities in neurodegeneration: from genetic data to drug discoveries

This is a past event.

Presented by Sara Saez-Atienzar, PhD, Neuromuscular Disease Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health

 

Dr. Saez-Atienzar is a Research Fellow at the National Institutes of Health (NIH). Her research focuses on data-driven approaches to facilitate preventive and therapeutic interventions for neurodegenerative diseases. During her postdoctoral research at NIH, Dr. Saez-Atienzar interrogated the biological mechanisms underlying Amyotrophic lateral sclerosis and Parkinson’s Disease by profiling genetic risk in population data. She has recently applied genetic-driven methods to investigate drugs that can delay the onset of neurodegenerative diseases. Before joining NIH, she obtained her Ph.D. from the Universidad Catolica de Valencia (Valencia, Spain), where she studied the cellular alterations associated with Parkinson’s disease and Huntington's disease in human cellular models.

Monday, February 6 at 10:00 a.m. to 11:00 a.m.

Public Health, A521
130 Desoto Street, Pittsburgh, 15261

EPI Special Seminar: A path for novel therapeutic opportunities in neurodegeneration: from genetic data to drug discoveries

Presented by Sara Saez-Atienzar, PhD, Neuromuscular Disease Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health

 

Dr. Saez-Atienzar is a Research Fellow at the National Institutes of Health (NIH). Her research focuses on data-driven approaches to facilitate preventive and therapeutic interventions for neurodegenerative diseases. During her postdoctoral research at NIH, Dr. Saez-Atienzar interrogated the biological mechanisms underlying Amyotrophic lateral sclerosis and Parkinson’s Disease by profiling genetic risk in population data. She has recently applied genetic-driven methods to investigate drugs that can delay the onset of neurodegenerative diseases. Before joining NIH, she obtained her Ph.D. from the Universidad Catolica de Valencia (Valencia, Spain), where she studied the cellular alterations associated with Parkinson’s disease and Huntington's disease in human cellular models.

Monday, February 6 at 10:00 a.m. to 11:00 a.m.

Public Health, A521
130 Desoto Street, Pittsburgh, 15261

Topic

Research

University Unit
Department of Epidemiology

Powered by the Localist Community Events Calendar ©